Rikke Bech
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dupilumab for Treatment-refractory Bullous Pemphigoid: A Case Series of Six Patients.
Journal: Acta dermato-venereologica
Published: March 25, 2026
Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer.
Journal: Cancer discovery
Published: December 19, 2024
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series.
Journal: Acta dermato-venereologica
Published: June 06, 2024
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 13, 2023
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Journal: Blood
Published: July 13, 2023
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid.
Journal: Frontiers in immunology
Published: February 28, 2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 27, 2022
Acral Necrosis in a COVID-19-Infected Man Treated with Botulinum Toxin Type A.
Journal: Case reports in dermatology
Published: September 14, 2021
Last Updated: 09/26/2026